Massachusetts regulators have moved to establish oversight of intoxicating hemp-derived cannabinoid products, assigning the Cannabis Control Commission (CCC) as the primary agency responsible for their regulation. This decision was reached during a commission meeting on Tuesday, after lawmakers deferred regulation of these products to the CCC.
Under the commission’s proposed framework, intoxicating hemp products will fall under the CCC’s jurisdiction, while cultivation oversight will continue to be managed by the Massachusetts Department of Agricultural Resources (MDAR). The commission also recommended that non-intoxicating hemp products be integrated into the CCC’s supply chain and allowed to be sold both within and beyond CCC-licensed retailers. However, expanding sales of these non-intoxicating products outside regulated outlets would require legislative approval, as it involves statutory changes beyond the commission’s authority.
CCC Commissioner Xiomara DeLobato noted the potential economic benefits of this approach, emphasizing that it could generate new revenue streams and enhance brand visibility for cannabis companies producing non-intoxicating hemp products. DeLobato framed the move as a step toward promoting social equity by facilitating capital flow within an industry that requires financial support.
The recommendations follow a directive from a recent state cannabis law instructing the CCC to assess the previously unregulated market for hemp-infused and cannabinoid products and to propose a regulatory path forward. Over recent years, intoxicating hemp items have grown in market presence, often operating in legal ambiguities and outside clear regulatory frameworks.
The commission voted unanimously to approve the report outlining its approach to regulating the hemp-derived cannabinoid sector. It tasked agency staff with preparing draft regulations ahead of its next meeting scheduled for December 10, when formal rulemaking discussions are expected to take place.
